The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
about
Virus and antibody dynamics in acute west nile virus infectionWest Nile virus infections projected from blood donor screening data, United States, 2003North American encephalitic arbovirusesYard flooding by irrigation canals increased the risk of West Nile disease in El Paso, Texas.The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st centuryA review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery.Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012.Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic.Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study.No evidence of West Nile virus infection in Dutch blood donors.Transfusion-associated transmission of West Nile virus, United States 2003 through 2005.Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification.Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis.Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process.
P2860
Q24570066-DF15A160-5952-4206-A01B-BD9B39BC756DQ31041026-FC600C86-E08E-4566-A7C8-5C3A29E48BFBQ33835377-F964C1A9-526C-4101-B87F-327738B758B6Q35674599-C6D5FD2F-76EB-4B63-8EBB-F16E0090EC2DQ36252455-AA2036C4-AA85-442A-B351-D0F03E2FCD6FQ36817997-125C923D-1389-4BBA-BDB3-9D0EDFA374F7Q37095548-3D936114-2D11-481E-A2D2-01ECE606D371Q37664406-2E85172A-3059-4907-BD3E-950398CB70A9Q38030586-89A80B46-1DD7-4AC9-812E-CBA5FF59CFF3Q40290912-B05908FE-009A-44AF-B195-894FFE0B98D9Q40324501-81344EC5-32D1-414F-874C-201877033FF2Q40347093-BE77A98F-CABE-45B2-8FAD-711D009C4B99Q40462028-98466C54-2E45-4196-AE26-38EF653E7C8FQ43040840-EDB1411E-9205-4DBD-92E5-F7877F2C9B30Q43041674-908E2CAF-B9D6-46A4-9C7D-CD72DBD1603DQ44964053-842914B3-D233-4785-9F50-940229B9B761Q46854672-4C7AF7D3-83E5-44E6-941F-2253C3C2E116Q50536784-A6707EB8-263F-4C77-B75A-332B017623C7
P2860
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
@en
type
label
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
@en
prefLabel
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
@en
P2093
P1433
P1476
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
@en
P2093
Celso Bianco
Deborah Todd
George Nemo
George Schreiber
Larry Pietrelli
Laurie Powell
Louis Katz
NHLBI Retrovirus Epidemiology Study (REDS)
Simone A Glynn
Steven Kleinman
P304
P356
10.1111/J.0041-1132.2005.04315.X
P577
2005-04-01T00:00:00Z